XM does not provide services to residents of the United States of America.

Applied Nutrition prices London IPO near lower end of range



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Applied Nutrition prices London IPO near lower end of range</title></head><body>

Oct 24 (Reuters) -Applied Nutrition IPO-APPL.L, a British sports nutrition-related business, on Thursday priced its London initial price offering at the lower end of its indicated range, valuing it at 350 million pounds ($452.87 million).

The company, which is backed by JD Sports JD.L, priced its offering 140 pence per share, at the lower end of its target range of 136 pence to 160 pence.



($1 = 0.7729 pounds)



Reporting by Yamini Kalia in Bengaluru; Editing by Mrigank Dhaniwala

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.